The role of squamous cell carcinoma antigen (SCC Ag) in outcome prediction after concurrent chemoradiotherapy and treatment decisions for patients with cervical cancer

At present, the standard treatment approach for locally advanced cervical cancer is concurrent chemoradiotherapy (CCRT). An elevated pretreatment squamous cell carcinoma antigen (SCC Ag) level is associated with extensive tumors and poor survival for patients with cervical cancer treated with defini...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jingxuan, Wang, Weiping, Wang, Yidan, Liu, Chengeng, Wang, Peichang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694518/
https://www.ncbi.nlm.nih.gov/pubmed/31416463
http://dx.doi.org/10.1186/s13014-019-1355-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6694518/
https://www.ncbi.nlm.nih.gov/pubmed/31416463
http://dx.doi.org/10.1186/s13014-019-1355-4

Ejemplares similares